A041830 logo

InBody Co.,Ltd Stock Price

KOSDAQ:A041830 Community·₩387.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

A041830 Share Price Performance

₩31,750.00
7750.00 (32.29%)
₩31,750.00
7750.00 (32.29%)
Price ₩31,750.00

A041830 Community Narratives

There are no narratives available yet.

Recent A041830 News & Updates

Insufficient Growth At InBody Co.,Ltd (KOSDAQ:041830) Hampers Share Price

Oct 02
Insufficient Growth At InBody Co.,Ltd (KOSDAQ:041830) Hampers Share Price

InBody Co.,Ltd Key Details

₩217.5b

Revenue

₩48.6b

Cost of Revenue

₩169.0b

Gross Profit

₩138.4b

Other Expenses

₩30.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
2.51k
Gross Margin
77.68%
Net Profit Margin
14.08%
Debt/Equity Ratio
0%

InBody Co.,Ltd Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and good value.

0 Risks
2 Rewards

About A041830

Founded
1996
Employees
342
CEO
Ki-Chul Cha
WebsiteView website
www.inbody.co.kr

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

South Korean Market Performance

  • 7 Days: 4.5%
  • 3 Months: 15.8%
  • 1 Year: 34.3%
  • Year to Date: 44.6%
The market has climbed 4.5% in the last 7 days, lead by the Information Technology sector with a gain of 8.8%. As for the past 12 months, the market is up 34%. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›